New drug cocktail aims to shrink Hard-to-Treat GI tumors
Disease control
Recruiting now
This phase 2 trial tests a new drug called LM-302 combined with other cancer treatments in people with advanced gastrointestinal cancers that have a specific marker (CLDN18.2). The study aims to see if the combination can slow tumor growth or shrink tumors. About 276 participants…
Phase: PHASE2 • Sponsor: LaNova Medicines Zhejiang Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 16:47 UTC